Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Imeka logo — We specialize in brain imaging specifically white matter, ne...

Imeka

We specialize in brain imaging specifically white matter, neuroinflammation, free-water and more. Imaging What Matters.

Founded 2011 Canada Sherbrooke, Canada 22 employees AI, Biotechnology +1

General Information

Company Name Imeka
Founded Year 2011
Location Canada Sherbrooke, Canada
Employees 22
Industries AI, Biotechnology, Health Care
Business Model B2B, SaaS, DaaS
Revenue Model Subscription, Usage Based, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Imeka. To contact Imeka, visit imeka.ca.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Imeka compare?

A PDF of Imeka and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Imeka soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Imeka

Imeka, founded in 2011 and headquartered in Canada, stands at the forefront of integrating AI with advanced brain imaging. This unique company specializes in mapping white matter integrity, providing crucial insights into neuroinflammation, demyelination, and axonal loss—a critical area in the treatment of neurodegenerative diseases. Their pioneering technology, which combines diffusion imaging with artificial intelligence, is particularly impactful in conditions such as Multiple Sclerosis, Alzheimer’s, and Parkinson’s diseases.

Led by renowned imaging expert Maxime Descoteaux, Ph.D., Imeka has cemented its position in the AI, Biotechnology, and Health Care industries. With its strong focus on non-invasive medical solutions, the company lowers development risks for pharmaceutical and biotech clients, addressing a vital aspect of the global health challenge.

Imeka recently received a grant investment from the Alzheimer's Drug Discovery Foundation on 24 October 2023, underscoring its potential and strategic importance in combating brain diseases. Investors eyeing the intersection of AI and medical imaging will find Imeka a compelling organization in which to explore possibilities.

Business keywords: brain imaging, white matter, neuroinflammation, diffusion imaging, neurodegenerative diseases, pharma, biotech, medical imaging, MRI, Maxime Descoteaux, Alzheimer's, Parkinson's, Multiple Sclerosis

Services & Products

Advanced Neuro Diagnostic Imaging (ANDI)
White Matter Imaging and Analysis
Quantitative Clinical Software
Brain Volumetry Capabilities

Target Customers

Clinicians in Neurology Radiologists Pharmaceutical Companies MRI Manufacturers

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Late VC Undisclosed 1
Alzheimer’s Drug Discovery Foundation
Alzheimer’s Drug Discovery Foundation
01 Oct 2023
Spinout Undisclosed 1
University of Sherbrooke
01 Jan 2011

Imeka Alternatives & Competitors

View All Alternatives
Imeka vs
Novoic
Novoic United Kingdom

Predicting brain disease from speech

Seed
6 employees
AI, Biotechnology
Imeka vs
Lys Therapeutics
Lys Therapeutics France

First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle n...

Non Equity Assistance
13 employees
Biotechnology, Health Care
Imeka vs
AIRAmed GmbH
AIRAmed GmbH Germany

AI software optimzes neuroradiological diagnostic and enables early detection of Alzheimer's & Co.

25 employees
AI, Health Care
View all alternatives

FAQ About Imeka

We specialize in brain imaging specifically white matter, neuroinflammation, free-water and more. Imaging What Matters.
Imeka was founded in 2011.
Imeka is headquartered in Sherbrooke, Canada.
Imeka operates in AI, Biotechnology and Health Care. Its work centres on brain imaging, white matter, neuroinflammation and diffusion imaging. Its customers include Clinicians in Neurology, Radiologists and Pharmaceutical Companies.
Imeka has a B2B, SaaS and DaaS business model. Its revenue comes from Subscription, Usage Based and Licensing.
Imeka has approximately 22 employees.
Imeka has completed 2 funding rounds.
Imeka offers: Advanced Neuro Diagnostic Imaging (ANDI), White Matter Imaging and Analysis, Quantitative Clinical Software, Brain Volumetry Capabilities.
Top alternatives and competitors to Imeka include Novoic, Lys Therapeutics, AIRAmed GmbH, Proclara Biosciences, Sudo Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Imeka and Novoic are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Imeka, https://bouncewatch.com/company/imeka, updated 27 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout